CSL PHARMA-ADVICE ApS: Financial statements 2016
CVR: 36501693
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
CSL PHARMA-ADVICE ApS (CVR 36501693) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 248,999 and a net result of DKK 145,190 compared with DKK 114,168 the year before. That is an increase of 60.4% compared with the year before. The profit margin was 58.3%. Equity in the 2016 report amounted to DKK 309,358. The solvency ratio was 82.7%.
- Revenue
- DKK 248,999
- Gross Profit
- DKK 189,090
- Profit/Loss
- DKK 145,190
- Equity
- DKK 309,358
- Total Assets
- DKK 374,011
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 249 t. | 189 t. | 145 t. | 309 t. | - |
| 2015 | 155 t. | 151 t. | 114 t. | 164 t. | - |
Official annual report
Find more companies like CSL PHARMA-ADVICE ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
CSL PHARMA-ADVICE ApS has published its annual report for 2015. Revenue came to DKK 155,235, and the net result was DKK 114,168.
About CSL PHARMA-ADVICE ApS
CSL PHARMA-ADVICE ApS was a Danish company of the type Anpartsselskab based in Lejre, founded in 2015. The company has been dissolved on 4 January 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. In 2022, the company reported a gross profit of DKK 30,604 and a net result of DKK 32,496 compared with DKK -44,528 the year before. Equity in the 2022 report amounted to DKK 133,890.